GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike M who wrote (4131)	4/24/2002 8:25:22 PM
From: Hank	Read Replies (2) of 5582

"I'm guessing we could see mid to upper 20's for PFE by next year..." Admittedly, the valuation for PFE is comparatively high these days but I wouldn't count on it going much lower than $30. On the other hand, there are better values in big pharma now,like BMY and MRK. PFE has a pretty aggressive long term game plan with respect to their in house discovery pipeline and they've always produced in the past. They don't need to merge to grow as much as other companies do. I would agree that we'll know more in about a year. It'll either be at $30 or $50.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next